Get started
BIO-RAD LABS INC. B DL 1BIO-RAD LABS INC. B DL 1BIO-RAD LABS INC. B DL 1

BIO-RAD LABS INC. B DL 1

No trades
See on Supercharts
Overview
Financials News Ideas Minds Forecast

BUW chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪7.68 B‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−10EUR
Net income (FY)
‪−577.42 M‬EUR
Revenue (FY)
‪2.42 B‬EUR
Shares float
‪107.77 K‬
Beta (1Y)
1.62

About Bio-Rad Laboratories, Inc.

Sector
Health Technology
Industry
Medical Specialties
CEO
Norman D. Schwartz
Website
bio-rad.com
Headquarters
Hercules
Employees (FY)
‪8.03 K‬
Founded
1952
FIGI
BBG00YYZ74P7
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BIO-RAD LABS INC. B DL 1 stocks are traded under the ticker BUW.
We've gathered analysts' opinions on BIO-RAD LABS INC. B DL 1 future price: according to them, BUW price has a max estimate of 381.74 EUR and a min estimate of 290.46 EUR. Watch BUW chart and read a more detailed BIO-RAD LABS INC. B DL 1 stock forecast: see what analysts think of BIO-RAD LABS INC. B DL 1 and suggest that you do with its stocks.
BUW reached its all-time high on Sep 13, 2021 with the price of 686 EUR, and its all-time low was 0.01 EUR and was reached on Jan 19, 2021. View more price dynamics on BUW chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track BIO-RAD LABS INC. B DL 1 financials in yearly and quarterly reports right on TradingView.
BIO-RAD LABS INC. B DL 1 is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
BUW earnings for the last quarter are 2.12 EUR per share, whereas the estimation was 2.01 EUR resulting in a 5.36% surprise. The estimated earnings for the next quarter are 1.90 EUR per share. See more details about BIO-RAD LABS INC. B DL 1 earnings.
BIO-RAD LABS INC. B DL 1 revenue for the last quarter amounts to ‪566.08 M‬ EUR, despite the estimated figure of ‪571.43 M‬ EUR. In the next quarter, revenue is expected to reach ‪595.89 M‬ EUR.
BUW net income for the last quarter is ‪355.81 M‬ EUR, while the quarter before that showed ‪316.84 M‬ EUR of net income which accounts for 12.30% change. Track more BIO-RAD LABS INC. B DL 1 financial stats to get the full picture.
No, BUW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 21, 2024, the company has ‪8.03 K‬ employees. See our rating of the largest employees — is BIO-RAD LABS INC. B DL 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO-RAD LABS INC. B DL 1 EBITDA is ‪526.38 M‬ EUR, and current EBITDA margin is 21.57%. See more stats in BIO-RAD LABS INC. B DL 1 financial statements.
Like other stocks, BUW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO-RAD LABS INC. B DL 1 stock right from TradingView charts — choose your broker and connect to your account.